NDC 47781-910-22 - testosterone cypionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 47781-910
- Requested NDC
- 47781-910-22
- Package NDCs from labels
- 47781-910-22, 47781-910-91
- Manufacturer
- Alvogen Inc.
- Effective date
- 2026-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Testosterone Cypionate Injection, USP CIII Rx Only | Alvogen Inc. | 2026-08-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Testosterone Cypionate Injection, USP CIII Rx Only | NuCare Pharmaceuticals, Inc. | 2025-05-05 | HUMAN PRESCRIPTION DRUG LABEL |
| testosterone cypionate - Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2024-06-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47781-910-22 | testosterone cypionate | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 | 4 | |
| 47781-910-91 | testosterone cypionate | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 47781-910-22 | ML - Milliliter | 47781-910 | 3ffef5b1-6f0a-4908-abfb-7f00c818c479 | 1 | 2023-02-06 |
| 47781-910-91 | ML - Milliliter | 47781-910 | 8a86a484-6276-4f85-a545-69ef2013eed7 | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Depo-Testosterone | TESTOSTERONE CYPIONATE | Asclemed USA, Inc. | 2f72be32-ede6-44d9-88a0-0653b53a3e47 | 2025-08-27 | Warnings, Adverse reactions | M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Hospira, Inc. | 6909596e-4bf7-4e11-8029-b89740a30aec | 2025-08-22 | Warnings, Adverse reactions | 835840 2047882 M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | NorthStar Rx LLC | 9ced69c7-cd37-efb6-1bf9-e21c01e56f5b | 2025-08-05 | Warnings, Adverse reactions | 2047882 M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | Xiromed LLC | cab949ca-fde9-c5a9-5561-21e98d86d078 | 2025-08-05 | Warnings, Adverse reactions | 835840 2047882 M0XW1UBI14 |
| AZMIRO | TESTOSTERONE CYPIONATE | Azurity Pharmaceuticals, Inc. | 235b5625-570d-3fba-e063-6394a90aa2d1 | 2025-07-25 | Warnings, Adverse reactions | 2047882 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Wilshire Pharmaceuticals | 58ff6e0d-cc0a-4455-8254-d883d26a3b6d | 2025-07-24 | Warnings, Adverse reactions | 835840 2047882 M0XW1UBI14 |
| Depo-Testosterone | TESTOSTERONE CYPIONATE | Pharmacia & Upjohn Company LLC | 735b5bf3-4464-412c-a072-1bd02f2e5380 | 2025-07-14 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | A-S Medication Solutions | e9d48af3-9514-4dc5-972c-0c1f2547e5c6 | 2025-07-09 | Warnings, Adverse reactions | 2047882 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Cipla USA Inc. | b8ac5e07-b7e3-4a60-b0d1-8b1f3ad0c478 | 2025-06-30 | Warnings, Adverse reactions | 835840 2047882 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Padagis US LLC | 4195516a-c8e6-457c-b805-43c9a3ca8b77 | 2025-06-03 | Warnings, Adverse reactions | 835840 2047882 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Eugia US LLC | f901e2b2-f143-4237-8e95-0d134585490b | 2025-06-03 | Warnings, Adverse reactions | 835840 2047882 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Hikma Pharmaceuticals USA Inc. | f60c5520-b336-44a2-95d5-f274939fa595 | 2025-06-01 | Warnings, Adverse reactions | 835840 2047882 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Hikma Pharmaceuticals USA Inc. | 5ca67491-4b30-4a47-af0a-be250215d1f0 | 2025-06-01 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Sun Pharmaceutical Industries, Inc. | 3653a602-4551-4e6c-84a7-31861f5dc482 | 2025-05-30 | Warnings, Adverse reactions | 835840 2047882 M0XW1UBI14 |
| TESTOSTERONE CYPIONATE | TESTOSTERONE CYPIONATE | Cipla USA Inc. | 78d55bad-4a5b-4e21-aeb8-a4c6346208be | 2025-05-09 | Warnings, Adverse reactions | 835840 2047882 M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | NuCare Pharmaceuticals, Inc. | 346604c7-22d0-60c5-e063-6394a90abf0b | 2025-05-05 | Warnings, Adverse reactions | ANDA207742 68071-3840-1 68071-3840 835840 34660d23-4120-6101-e063-6394a90ad6ab 346604c7-22d0-60c5-e063-6394a90abf0b M0XW1UBI14 |
| testosterone cypionate | TESTOSTERONE CYPIONATE | NuCare Pharmaceuticals,Inc. | 335ff614-15ec-0792-e063-6294a90a2f08 | 2025-04-22 | Warnings, Adverse reactions | ANDA207742 2047882 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | NuCare pgarmaceuticals,Inc. | 30b453b9-25ef-8262-e063-6394a90a24c2 | 2025-03-19 | Warnings, Adverse reactions | 835840 M0XW1UBI14 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Bryant Ranch Prepack | 5a0bba6a-e8da-4b12-af63-eb27b1cca9e6 | 2025-02-04 | Warnings, Adverse reactions | 2047882 M0XW1UBI14 |
| Chemtox | TRITICUM AESTIVUM, BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, RHAMNUS PURSHIANA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, LYMPH NODE (SUIS), THYROIDINUM (SUIS), BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, | BioActive Nutritional, Inc. | a480e5f4-5f9e-4b23-b257-b0ac1ebfc115 | 2025-01-07 | Warnings | LKG8494WBH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.